baber/WOPTO huggingface dataset:
Patent SK-286870-B6 (SK)
Title: Immortalised cell lines derived from normal human skin tissues
Inventor: BAUR MARKUS
IPC: C12N15/09
Filed: 1999-04-07
Abstract: A human keratinocyte cell line immortalised by means of functionale tumor genes coming from at least SV40 virus and human papilloma virus 16 wherein it (1) is non-tumorigenic, (2) conserves tme capacity of differentiation and for tme expression of proteins and enzymes expressed by normal differentiated keratinocytes even after an elevated number of passages in culture the said elevated number of passages comprising at least 10 passages in culture, and (3) forms a stratified and polarised epithelium comprising an ortho-keratosic stratum corneum when cultivated in an organo-typical culture in a media without serum and without a layer of nourishing cells. The invention further concerns the method of obtaining immortalised keratinocyte cell lines derived from normal human skin tissues in vitro, the use of human keratinocyte cell line and artificial skin comprising a keratinocyte cell lines .
Patent BR-PI0206903-B8 (BR)
Inventor: DULCE ELENA CASARINI
IPC: C12Q1/37
Filed: 2002-12-20
Abstract: A method of detecting a predisposition for the development of a kidney lesion in an individual including detecting a presence of at least three angiotensin converting enzyme isoforms in an aliquot of fresh or concentrated biological fluids, cells or tissues obtained from the individual; and quantifying the presence of the at least three antiotension converting enzyme isoforms.
Patent BR-9609335-B8 (BR)
Inventor: ALBERT RAINER
IPC: A61K38/22
Filed: 1996-06-28
Abstract: Somatostain analogues comprising the amino acid sequence of the formula (I): -(D/L)Trp-Lys-X1-X2, wherein X1 is a substituted Thr, Ser, Tyr, Glu or Cys residue and X2 is an alpha-amino acid having an aromatic residue on the Calpha side chain, or an amino acid unit selected from Dab, Dpr, Dpm, His (Bzl)HyPro, thienyl-Ala, cyclohexyl-Ala and t.-butyl-Ala, the residue Lys of said sequence corresponding to the residue Lys9 of the native somatostatin-14, in free form, in salt form or complexed with a detectable element have interesting pharmacological properties.
Patent EP-1251379-B8 (EP)
Inventor: HUNG VIET NGO
IPC: G02B6/38
Filed: 2002-04-17
Granted: 2009-03-11
Abstract: Guide boot (10) for fiber optic cable comprising an outer sleeve or body that defines an inner passageway, and has a first end (12) for receiving the cable and a termination port (17). The inner passageway is dimensioned to allow a user to insert a cable through the passageway. The body with the inner passageway is used for guiding, bending, and/or twisting the cable. The body is angled at the desired angle (or radius of curvature), such as about 45 degrees or about 90 degrees. The body preferably has an outer diameter that decreases toward the to first end. The inner passageway is preferably tapered to allow the cable to twist along the length of the boot without interference. The cable can be inserted into and through the guide boot without any twisting, and the cable can thereafter be twisted or otherwise rotated before the guide boot is connected with the termination plug. The termination plug has a first end to receive the cable and to connect with the guide boot using, for example, a friction fit. Locking tabs are preferably provided in the end to engage the termination port of the guide boot, thereby holding the guide boot in connection with the termination plug. <IMAGE>
Patent EP-1442019-B8 (EP)
Inventor: FREYNE EDDY JEAN EDGARD
IPC: C07D239/42
Filed: 2002-10-29
Granted: 2013-10-30
Abstract: This invention concerns a compound of formula a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine and a stereochemically isomeric form thereof, wherein ring A represents a 6-membered heterocycle; R<SUP>1 </SUP>is hydrogen; aryl; formyl; C<SUB>1-6</SUB>alkylcarbonyl; optionally substituted C<SUB>1-6</SUB>alkyl; C<SUB>1-6</SUB>alkyloxycarbonyl; optionally substituted C<SUB>1-6</SUB>alkyloxyC<SUB>1-6</SUB>alkylcarbonyl; X is a direct bond or a linker atom or group; Z is O or S; R<SUP>2 </SUP>is hydrogen, C<SUB>1-10</SUB>alkyl, C<SUB>2-10</SUB>alkenyl, C<SUB>2-10</SUB>alkynyl, a carbocycle or a heterocycle, each of said groups may optionally be substituted; R<SUP>3 </SUP>is hydrogen; hydroxy; halo; optionally substituted C<SUB>1-6</SUB>alkyl or C<SUB>2-6</SUB>alkenyl or C<SUB>2-6</SUB>alkynyl; C<SUB>1-6</SUB>alkyloxy; C<SUB>1-6</SUB>alkylthio; C<SUB>1-6</SUB>alkyloxycarbonyl; C<SUB>1-6</SUB>alkylcarbonyloxy; carboxyl; cyano; nitro; amino; mono- or di(C<SUB>1-6</SUB>alkyl)amino; polyhaloC<SUB>1-6</SUB>alkyl; polyhaloC<SUB>1-6</SUB>alkyloxy; polyhaloC<SUB>1-6</SUB>alkylthio; R<SUP>21</SUP>; R<SUP>21</SUP>-C<SUB>1-6</SUB>alkyl; R<SUP>21</SUP>-O-; R<SUP>21</SUP>-S-; R<SUP>21</SUP>-C(-O)-; R<SUP>21</SUP>-S(-O)<SUB>p</SUB>-; R<SUP>7</SUP>-S(-O)<SUB>p</SUB>-; R<SUP>7</SUP>-S(-O)<SUB>p</SUB>-NH-; R<SUP>21</SUP>-S(-O)<SUB>p</SUB>-NH-; R<SUP>7</SUP>-C(-O)-; -NHC(-O)H; -C(-O)NHNH<SUB>2</SUB>; R<SUP>7</SUP>-C(-O)-NH-; R<SUP>21</SUP>-C(-O)-NH-; -C(-NH)R<SUP>7</SUP>; -C(-NH)R<SUP>21</SUP>; R<SUP>4a </SUP>or R<SUP>4b </SUP>each independently represent hydrogen, R<SUP>8</SUP>, -Y<SUB>1</SUB>-NR<SUP>9</SUP>-Y<SUB>2</SUB>-NR<SUP>10</SUP>R<SUP>11</SUP>, -Y<SUB>1</SUB>-NR<SUP>9</SUP>-Y<SUB>1</SUB>-R<SUP>8</SUP>, -Y<SUB>1</SUB>-NR<SUP>9</SUP>R<SUP>10</SUP>; provided that -X-R<SUP>2 </SUP>and/or R<SUP>3 </SUP>is other than hydrogen; their use, pharmaceutical compositions comprising them and processes for their preparation.
Patent EP-1838589-B8 (EP)
Inventor: LOSSAU HARALD
IPC: G06K19/077
Filed: 2005-12-15
Granted: 2011-09-14
Abstract: In a container (1) for transporting and storing substances that is provided with a transponder for radio frequency identification, it is provided that the container exhibits a substantially cylinder-shaped main section (12) having a curved lateral surface, and that the transponder includes an electronic memory (21) and, as a coupling element, an antenna coil (22), the antenna coil (22) being disposed in or on a wall surface of the container (1) and with its axis parallel to the cylinder axis of the main section (12). According to the present invention, the antenna coil (22) is disposed in the region of the cylinder-shaped main section (12) of the container on the lateral surface of the cylinder and exhibits one or more windings around the cylinder axis.
Patent EP-1705405-B8 (EP)
Inventor: KOLLMANN HELGA
IPC: F16H55/18
Filed: 2006-01-26
Granted: 2008-02-20
Abstract: The method involves adjusting a flank clearance of toothing contacts using a detachable coating, which is applied on a side within a tooth clearance (3) between tooth flanks in a layer thickness corresponding to the flank clearance. The coating is provided with a mixture of 5 to 20 percentage of polymer material, 5 to 20 percentage of solid lubricants and 75 percentage of solvent with respect to the entire weight of the mixture.
Patent EP-1749517-B8 (EP)
Inventor: TENENGAUZER RUTH
IPC: A61K9/20
Filed: 2006-01-17
Granted: 2008-10-22
Abstract: A method of formulating linezolid to provide a solid pharmaceutical composition comprising linezolid Form IV substantially free of linezolid Form II, methods of treating a condition responsive to linezolid in a patient comprising administering to the patient a solid pharmaceutical composition comprising linezolid form IV substantially free of linezolid Form II.
Patent EP-2217596-B8 (EP)
Inventor: XIA YAN
IPC: A61P3/00
Filed: 2008-10-20
Granted: 2013-11-20
Abstract: The present invention relates to Bicyclic Heterocycle Derivatives, compositions comprising a Bicyclic Heterocycle Derivative, and methods of using the Bicyclic Heterocycle Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of GPR119 in a patient.
Patent BR-PI0510778-B8 (BR)
Inventor: ANDERS CARLSSON
IPC: A61K9/00
Filed: 2005-05-06
Abstract: There is provided pharmaceutical compositions for the treatment of rhinitis by, for example, nasal or ocular administration comprising zwitterionic cetirizine, a polar lipid liposome and a pharmaceutical acceptable aqueous carrier. The compositions are preferably homogeneous in their nature.
Patent BR-PI0702003-B8 (BR)
Inventor: JEAN-PIERRE PAGES
IPC: D03C1/00
Filed: 2007-04-10
Abstract: In a dobby with two controlled bolts (10, 11) for rotationally coupling a drive (8) and an actuator (4), where a spring (19) forces the bolts into a configuration in which the bearing surfaces (103, 113) engage drive surfaces (84A, 84B) and controllers (13, 14) displace the bolts against the spring, the spring operates directly and indirectly on the first and second bolts respectively. The controllers displace the first bolt against the spring, while the second remains in engagement configuration. A rotary dobby has (for each plate) an oscillating part coupled with a warp frame, associated with an actuator (4) loosely mounted on the main shaft (1) of the ratiere; a drive fixed to the shaft; and two controlled bolts (10, 11) for rotationally coupling a drive (8) and the actuator, each mounted on the actuator. The first bolt (10) has a first surface (103) bearing selectively against first drive surface(s) (84A), forming a motive force transmission interface between the drive and actuator; and the second bolt (11) has a second surface (113) bearing selectively against second drive surface(s) (84B), forming a transmission interface for received force from the actuator to the drive. A first spring (19) forces the bolts toward an engagement configuration in which their bearing surfaces (103, 113) engage the drive surfaces. Controllers (13, 14) displace the bolts against the action of the spring. The novel features are that the spring operates directly and indirectly on the first and second bolts respectively; and the controllers displace the first bolt against the action of the spring, while the second bolt remains in the engagement configuration. Independent claims are included for: (1) a corresponding method for controlling a rotary dobby; (2) a weaving loom equipped with the dobby; and (3) a sub-assembly for a dobby, comprising an eccentric actuating element (4), a rod mounted on the actuator and a pivoting arm for connecting the rod with a warp frame.
Patent BR-PI0702327-B8 (BR)
Title: artigo absorvente conformável
Inventor: LEONARD G ROSENFELD
IPC: A61F13/15
Filed: 2007-03-15
Abstract: ARTIGO ABSORVENTE CONFORMÁVEL. A presente invenção refere-se um artigo absorvente incluindo uma camada de cobertura, uma camada de barreira e um sistema absorvente disposto entre a camada de cobertura e a camada de barreira, o artigo absorvente sendo ajustável e possuindo os atributos de absorvência requeridos de um absorvente higiênico.
Patent BR-PI0813307-B8 (BR)
Title: composição imunogênica, vacina, e, processo para fabricar a vacina
Inventor: JAN POOLMAN
IPC: A61K39/09
Filed: 2008-06-24
Abstract: composição imunogênica, vacina, e, processo para fabricar a vacina composição imunogênica a presente invenção divulga uma composição imunogênica que compreende conjugados de sacarídeo capsular de s. pneumoniae dos sorotipos 19a e 19f em que 19a é conjugado a um primeiro toxóide bacteriano e 19f é conjugado a um segundo toxóide bacteriano. vacinas, métodos de fabricar vacinas e usos das vacinas também são descritos.
Patent BR-PI0820629-B8 (BR)
Title: Sistema de bobina eletromagnética para aço fundido no molde
Inventor: TAKATANI KOUJI
IPC: H01F7/20
Filed: 2008-10-10
Abstract: sistema de bobina eletromagnética para aço fundido no molde. a presente invenção refere-se a um sistema de bobina eletromagnética para iingota-mento contínuo de aço no molde, configurado para ativar seletivamente a agitação eletromagnética e a frenagem eletromagnética do aço fundido (2) pela aplicação de uma corrente contínua ou de pelo menos uma corrente alternada trifásica a uma bobina eletromagnética disposta em torno do lado largo (3b) de um molde. a bobina eletromagnética é fornecida com dois dentes (21a) se estendendo a partir da culatra (21b). um enrolamento interno (22) é fornecido em torno dos dois dentes (21a), e um enrolamento externo (23) é também fornecido em torno do lado externo dos dois dentes (21a) fornecidos com o enrolamento interno (22). o comprimento (l) dos dentes (21a) é especificado para ser pelo menos duas vezes a largura (w) dos den-tes (21a). a bobina eletromagnética é disposta de modo que haja n bobinas dispos-tas em cada lado largo (3b), onde (n) é um número natural maior que ou igual a 2, e o núcleo (21) de um material magnético é disposto em uma faixa se estendendo em uma direção vertical a partir da posição do menisco e incluindo o orifício de saída (la) do bocal de imersão (1). uma capacidade de agitação bem como uma capacidade de frenagem suficientes podem ser garantidas, enquanto se economiza energia e se reduz o peso do núcleo (12)
Patent BR-PI0914081-B8 (BR)
Title: dispositivo de expansão de stents
Inventor: DAVID FRANKLYN WILLIAMS
IPC: A61F2/95
Filed: 2009-10-08
Abstract: dispositivo de expansão de stents um dispositivo de expansão de stents (1) sobre o qual um stent (2) pode ser fixado para fins de liberação em uma posição operativa em um corpo humano. o dispositivo compreende uma série de asas alongadas (16), cada uma das quais com um comprimento consistente com o comprimento de um stent a ser expandido utilizando o dispositivo de expansão, em que as asas são dispostas em circunferência em volta de um corpo central (10) que se estende a partir de um cateter (14) e é operável por meio dele. as asas são móveis entre uma posição de liberação movida radialmente e posições expandidas nas quais são deslocadas radialmente para fora do corpo. um trajeto de fluxo (105) é definido no lado interno das asas nas suas posições expandidas e uma válvula temporária (68) é fornecida nesse trajeto de fluxo permitir o fluxo de sangue através do trajeto de fluxo predominantemente em uma direção. um balão anular inflável (80) é preferencialmente fornecido sobre as asas para causar expansão final do stent. os braços posicionadores, (40) são expandidos a partir do corpo para assistir no posicionamento do corpo no interior de uma válvula cardíaca natural (101).
Patent BR-PI0924899-B8 (BR)
Title: Síntese hmo
Inventor: STEFAN JENNEWEIN
IPC: C12N15/63
Filed: 2009-06-08
Abstract: SÍNTESE HMO. A presente invenção se refere a uma célula estavelmente cultivada em um meio, cuja célula é ajustada para a produção de oligossacarídeos, a célula sendo transformada para compreender pelo menos uma sequência de ácido nucléico que codifica uma enzima envolvida na síntese de oligossacarídeo. Além disto, a célula é transformada para compreender pelo menos uma sequência de ácido nucléico que codifica uma proteína da família de transportador de efluxo de açúcar, um homólogo funcional ou um derivado deste. Adicionalmente, a invenção inclui um método para a produção de oligossacarídeos que envolvem a célula acima descrita.
Patent AU-2002347900-B8 (AU)
Title: Bronchial flow control devices and methods of use
Inventor: HUNDERTMARK RONALD
IPC: A61F2/04
Filed: 2002-10-10
Granted: 2006-01-12
Abstract: Methods and systems for lung volume reduction of a patient are described. The methods include implanting a flow control device in a bronchial passageway of the lung. The flow control device regulates fluid flow through the bronchial passageway and includes a valve protector that at least partially surrounds a valve member. The valve protector has sufficient rigidity to maintain the shape of the valve member against compression.
Patent AU-2009202476-B8 (AU)
Title: Automated tissue engineering system
Inventor: HAGG RUPPERT
IPC: A61L27/00
Filed: 2009-06-15
Granted: 2012-07-19
Abstract: The invention provides systems, modules, bioreactor and methods for the 5 automated culture, proliferation, differentiation, production and maintenance of tissue engineered products. In one aspect is an automated tissue engineering system comprising a housing, at least one bioreactor supported by the housing, the bioreactor facilitating physiological cellular functions and/or the generation of one or more tissue constructs from cell and/or tissue sources. A fluid containment system is supported 10 by the housing and is in fluid communication with the bioreactor. One or more sensors are associated with one or more of the housing, bioreactor or fluid containment system for monitoring parameters related to the physiological cellular functions and/or generation of tissue constructs; and a microprocessor linked to one or more of the sensors. The systems, methods and products of the invention find use 15 in various clinical and laboratory settings. W:Mark Wickhan\700M 799999729807\For division[729807 pS I -sd clims 180509.do
Patent BR-112015002817-B8 (BR)
Title: Aditivo de solução eletrolítica para bateria secundária de lítio, e solução eletrolítica não aquosa e bateria secundária de lítio incluindo o aditivo
Inventor: GWANG YEON KIM
IPC: H01M10/052
Filed: 2014-10-31
Abstract: ADITIVO DE SOLUÇÃO ELETROLÍTICA PARA BATERIA SECUNDÁRIA DE LÍTIO, E SOLUÇÃO ELETROLÍTICA NÃO AQUOSA E BATERIA SECUNDÁRIA DE LÍTIO INCLUINDO O ADITIVO. É fornecida uma solução eletrolítica não aquosa incluindo um solvente orgânico não aquoso, um sal de lítio à base de imida e pelo menos um aditivo selecionado a partir do grupo que consiste em lítio difluoro bis(oxalato)fosfato (LiDFOP), fosfato de (trimetilsilil)propila (TMSPa), 1,3-propeno sultana (PRS), e sulfato de etileno (ESa), como um aditivo de solução eletrolítica. De acordo com o aditivo de solução eletrolítica para uma bateria secundária de lítio da presente invenção, o aditivo de solução eletrolítica pode melhorar as características de produção em altas e baixas temperaturas e pode evitar um fenômeno de inchaço por suprimir a decomposição do PF6- sobre a superfície de um cátodo, que pode ocorrer durante um ciclo de alta temperatura de uma bateria secundária de lítio, incluindo o aditivo de solução eletrolítica, e evitar uma reação de oxidação de uma solução eletrolítica.
Patent BR-112015004463-B8 (BR)
Title: Dispositivo hiperbárico e processos para produzir vacinas inativadas e para redobrar/solubilizar proteínas recombinantes
Inventor: NICOLAS PIERRE YVES CARBOULEC
IPC: C12N15/62
Filed: 2013-08-30
Abstract: DISPOSITIVO HIPERBÁRICO E PROCESSOS PARA PRODUZIR VACINAS INATIVADAS E PARA REDOBRAR/SOLUBILIZAR PROTEÍNAS RECOMBINANTES A invenção se refere a dispositivos hiperbáricos para inativar microrganismos e vírus, preservando a imunogenicidade dos mesmos, e para fazer e produzir as proteínas imunogênicas ou terapêuticas solúveis, desagregadas, redobradas ou ativas a partir dos corpos de inclusão produzidos a partir de procariotos ou eucariotos. A invenção engloba métodos hiperbáricos para inativar organismos patogênicos e processos para a produção de composições de vacina usando os patógenos inativados. Os microrganismos hiperbaricamente inativados são mais seguros e mais imunogênicos do que os microrganismos quimicamente inativados. Da mesma forma, as proteínas solubilizadas têm propriedades superiores em comparação com as proteínas mais fortemente agregadas, incluindo um grau reduzido de reações imunológicas não específicas.
Patent BR-122016015852-B8 (BR)
Title: peptídeos de liberação de hormônio do crescimento, seu uso e método de determinação da habilidade de um composto em se ligar a um receptor de ghs
Inventor: ZHENG XIN DONG
IPC: C07K7/06
Filed: 2003-08-08
Abstract: a presente invenção refere-se a peptídeos e compostos peptidomiméticos geralmente de acordo com a fórmula (i), e seus sais farmaceuticamente aceitáveis, que são úteis como análogos de ghrp: r1 a2-a3-a4-a5-r2 (i) ou um seu sal farmaceuticamente aceitável, onde: a1 é aib, apc ou inp; a2 é d-bal, d-bip, d-bpa, d-dip, d-1nal, d-2nal, d-ser(bzl) ou d-trp; a3 é d-bal, d-bip, d-bpa, d-dip, d-1nal, d-2nal, d-ser(bzl) ou d-trp; a4 é 2fua, orn, 2pal, 3pal, 4pal, pff, phe, pim, taz, 2thi, 3thi, thr(bzl); a5 é apc, dab, dap, lys, orn ou deletado; r1 é hidrogênio, (c1-6)alquila, (c5-14)arila, (c1-6)alquil(c5-14)arila, (c3-8)cicloalquila ou (c2-10)acila; e r2 é oh ou nh2; e composições farmacêuticas e métodos para seu uso.
Patent EP-1265307-B9 (EP)
Title: Pile polymere
Inventor: SADA TSUTOMU
IPC: H01M4/583
Filed: 2000-11-17
Granted: 2008-12-03
Abstract: Une pile polymère comprend une électrode négative contenant un matériau en carbone en tant que matériau actif, une couche d'électrolyte ainsi qu'une électrode positive comprenant un chalcogénure contenant du lithium en tant que matériau actif, caractérisé en ce que la couche d'électrolyte contient un composé conducteur d'ions ainsi qu'une fibre polymère, et le matériau en carbone contient des particules de graphite présentant du carbone amorphe collé sur leur surface. La pile polymère est capable d'empêcher la décomposition du matériau conducteur d'ions à l'aide de particules de graphite.
Patent EP-1399423-B9 (EP)
Inventor: BRENDEL JOACHIM
IPC: A61K31/4245
Filed: 2002-05-31
Granted: 2008-02-27
Abstract: L'invention concerne les composés de la formule (I) dans laquelle R(1) à R(7) ont la signification donnée dans les revendications. Les composés selon l'invention agissent sur le canal de potassium Kv1.5 et inhibent un flux de potassium appelé « rectificateur retardé d'activation ultra-rapide » dans l'oreillette. Ainsi, lesdits composés servent notamment de nouveaux agents actifs anti-arythmisants, en particulier pour le traitement et la prophylaxie d'arythmies auriculaires, par ex. de la fibrillation auriculaire ou du flutter auriculaire.
Patent AU-2003222242-B9 (AU)
Title: Diversity antenna for UNII access point
Inventor: ANDERSON FRED
IPC: H01Q1/08
Filed: 2003-03-04
Granted: 2008-10-23
Abstract: A combination of near omni-directional antennas and internal patch antennas, all built into an access point in accordance with FCC requirements. Typically a printed antenna array is used for the near omni-directional antenna, and the internal patch antenna is a TM10 mode stacked patch antenna. A mechanical detect switch changes antenna types automatically, depending on the rotation state of the antenna system. Alternately, a configuration utility enables a user to select the antenna type for the access point when it is installed in the field. This arrangement gives the UNII access point flexibility to be mounted in various orientations and match the characteristics of the antenna to the installation requirements.
Patent AU-2007296939-B9 (AU)
Title: Hyaluronic acid derivatives obtained via "click chemistry" crosslinking
Inventor: GALESSO DEVIS
IPC: C08B37/00
Filed: 2007-09-05
Granted: 2012-07-19
Abstract: Crosslinked derivatives of polycarboxylated polysaccharides are described, wherein at least one of the polysaccharide chains consists of hyaluronic acid or a derivative thereof, crosslinked by means of reactions of the "click chemistry" type and their use in the field of viscosupplementation, plastic surgery, oncologic and reconstructive surgery and also as matrices for controlled release systems of biologically and/or pharmacologically active molecules and/or macromolecules.
Patent AU-2018101509-B9 (AU)
Title: Conveyor belt wear assessment and conveyor belt coating
Inventor: ARMSTRONG NEIL MICHAEL
IPC: B65G15/34
Filed: 2018-10-11
Granted: 2020-12-24
Abstract: System and method for coating a wear surface of a conveyor belt with a wear 
resistant coating includes applying 14 a primer 28 to at least a portion of the wear 
surface 18a of the belt 18 and subsequently applying 16 wear resistant coating 30 
over the primer 28. The belt can be moving and can be cleaned 12 before 
priming. The primer can be an epoxy primer and the wear resistant coating can 
be a polyurea elastomer, and can include isocyanate and resin. The primer 
and/or wear resistant coating can be spray applied, which can be while the belt is 
moving. High-pressure, heated plural spray proportioning equipment can be used 
to apply the coating. 3D light scanning of the belt, such as laser or IR, which can 
provide overlap on the original thickness to generate a complete wear resistant 
profile over the scanned surface. A light reflective coating can be used to over a 
target area to assist 3D scanning.